OII insider files Form 144 to sell 10,000 shares via J.P. Morgan
Rhea-AI Filing Summary
Oceaneering International, Inc. (OII) Form 144 notice shows a proposed sale of 10,000 shares of common stock through J.P. Morgan Securities LLC on or about 09/02/2025 with an aggregate market value of $244,000. The filing reports total shares outstanding of 100,207,596. The 10,000 shares were acquired as compensation in four tranches between 02/15/2015 and 02/24/2018 (3,000; 4,000; 2,000; 1,000 respectively). The filer certifies no undisclosed material adverse information and indicates no sales of issuer securities in the past three months.
Positive
- Complete acquisition history provided with dates and amounts for all 10,000 shares
- Broker and sale date specified (J.P. Morgan Securities LLC, approx. 09/02/2025)
- Filer attests no undisclosed material adverse information and reports no sales in the past three months
Negative
- None.
Insights
TL;DR: Routine Rule 144 notice for an insider-derived block of 10,000 shares; size is immaterial to market cap.
The filing documents a proposed brokered sale of 10,000 common shares via J.P. Morgan with a stated market value of $244,000 against 100.2 million shares outstanding, representing ~0.01% of outstanding stock. Shares were acquired as compensation across 2015–2018. There are no reported recent sales and the filer affirms no undisclosed material adverse information. This appears to be a standard disposition under Rule 144 rather than a signal of company-specific news.
TL;DR: Disclosure follows procedural requirements; timing and compensation origin are explicitly stated.
The notice provides acquisition dates, compensation origin, and broker details, meeting Form 144 disclosure norms. The signature statement about material information and absence of recent sales is present. There is no indication of a trading plan date or other special conditions disclosed. From a governance perspective, the filing supplies required transparency on insider-derived share sales but contains no governance concerns on its face.